Quantcast

East Cleveland News

Thursday, November 28, 2024

FDA: 2 companies in cities within Cuyahoga County received 13 citations in March

Webp r74yaky65u3uuv4dhbep5jgucuk5

Robert M. Califf, M.D. Commissioner of Food and Drugs - FDA | Official Website

Robert M. Califf, M.D. Commissioner of Food and Drugs - FDA | Official Website

There were two companies in cities associated with Cuyahoga County that received FDA citations as a result of two inspections conducted in the county in March, according to reports from the U.S. Food and Drug Administration (FDA).

This is unchanged from the number of companies cited in the previous month.

The citations in the county include:

  • Procedures for monitoring and control of process parameters for a validated process have not been adequately established.
  • Procedures have not been adequately established to control product that does not conform to specified requirements.
  • Management with executive responsibility has not reviewed the suitability and effectiveness of the quality system with sufficient frequency.

Both companies cited were involved in the Devices sector.

Both companies cited should take voluntary actions to correct their managing operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Companies located within Cuyahoga County Cities and the citations they received in March
Company NameArea of BusinessInspection DateIssue Cited
New COS, Inc.Devices03/14/2024Lack/Inad procedure-Monitoring/Control of Validated Proces
New COS, Inc.Devices03/14/2024Nonconforming product, Lack of or inadequate procedures
Transdermal Cap, Inc.Devices03/26/2024Management review - defined interval, sufficient frequency
Transdermal Cap, Inc.Devices03/26/2024Quality Audit/Reaudit - conducted
Transdermal Cap, Inc.Devices03/26/2024Design Validation - Risk analysis not performed/inadequate
Transdermal Cap, Inc.Devices03/26/2024Design history file
Transdermal Cap, Inc.Devices03/26/2024Evaluation and Selection, Suppliers, Contractors, etc.
Transdermal Cap, Inc.Devices03/26/2024Supplier oversight
Transdermal Cap, Inc.Devices03/26/2024Acceptable supplier records, inadequate records
Transdermal Cap, Inc.Devices03/26/2024Calibration, Inspection, etc. Procedures Lack of or Inadequ
Transdermal Cap, Inc.Devices03/26/2024Nonconforming product control
Transdermal Cap, Inc.Devices03/26/2024Documentation
Transdermal Cap, Inc.Devices03/26/2024Investigation of device failures

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS